Polymorphisms in TP53 and MDM2 combined are associated with high grade endometrial cancer. (Q51840083)

13 April 2018

title

Polymorphisms in TP53 and MDM2 combined are associated with high grade endometrial cancer. (English)

1 reference

13 April 2018

author

John Attia

6

1 reference

13 April 2018

Ute Hamann

8

object named as

Ute Hamann

1 reference

13 April 2018

Katie A Ashton

1

1 reference

13 April 2018

Anthony Proietto

2

1 reference

13 April 2018

Geoffrey Otton

3

1 reference

13 April 2018

Ian Symonds

4

1 reference

13 April 2018

Mark McEvoy

5

1 reference

13 April 2018

Michael Gilbert

7

1 reference

13 April 2018

Rodney J Scott

9

1 reference

13 April 2018

language of work or name

English

0 references

publication date

3 February 2009

1 reference

13 April 2018

published in

Gynecologic Oncology

1 reference

13 April 2018

volume

113

1 reference

13 April 2018

page(s)

109-114

1 reference

13 April 2018

issue

1

1 reference

13 April 2018

Molecular pathogenesis and prognostic factors in endometrial carcinoma

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.12.036

Cancer risk in hereditary nonpolyposis colorectal cancer syndrome: later age of onset.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.12.036

p53 mutations in human cancers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.12.036

p53, the cellular gatekeeper for growth and division

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.12.036

The p53 tumor suppressor gene: from molecular biology to clinical investigation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.12.036

mdm-2 inhibits the G1 arrest and apoptosis functions of the p53 tumor suppressor protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.12.036

Regulation of p53 stability by Mdm2

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.12.036

MDM2 and human malignancies: expression, clinical pathology, prognostic markers, and implications for chemotherapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.12.036

Progressive derailment of cell cycle regulators in endometrial carcinogenesis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.12.036

p53 Genotypes and Haplotypes Associated With Lung Cancer Susceptibility and Ethnicity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.12.036

Role of a p53 polymorphism in the development of human papillomavirus-associated cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.12.036

Chemosensitivity linked to p73 function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.12.036

A common polymorphism acts as an intragenic modifier of mutant p53 behaviour

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.12.036

A single nucleotide polymorphism in the MDM2 promoter attenuates the p53 tumor suppressor pathway and accelerates tumor formation in humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.12.036

Germline polymorphism of cancer susceptibility genes in gynecologic cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.12.036

Germline polymorphism of p53 codon 72 in gynecological cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.12.036

p53 and p21 genetic polymorphisms and susceptibility to endometrial cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.12.036

Susceptibility to endometrial cancer: influence of allelism at p53, glutathione S-transferase (GSTM1 and GSTT1) and cytochrome P-450 (CYP1A1) loci

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.12.036

Association of p73 G4C14-to-A4T14 polymorphism at exon 2 and p53 Arg72Pro polymorphism with the risk of endometrial cancer in Japanese subjects.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.12.036

Association of p53 mutations and a codon 72 single nucleotide polymorphism with lower overall survival and responsiveness to adjuvant radiotherapy in endometrioid endometrial carcinomas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.12.036

Association between a functional single nucleotide polymorphism in the MDM2 gene and sporadic endometrial cancer risk.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.12.036

MDM2 SNP309 is associated with endometrial cancer risk

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.12.036

A simple salting out procedure for extracting DNA from human nucleated cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.12.036

Age of diagnosis of colorectal cancer in HNPCC patients is more complex than that predicted by R72P polymorphism in TP53.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.12.036

The MspI polymorphism in intron 6 of p53 (TP53) detected by digestion of PCR products

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.12.036

Do MDM2 SNP309 and TP53 R72P interact in breast cancer susceptibility? A large pooled series from the breast cancer association consortium

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.12.036

10.1016/J.YGYNO.2008.12.036

7 January 2021

Identifiers

DOI

1 reference

13 April 2018

PubMed ID

19193430

1 reference

13 April 2018